Gao Jian, Liang Li, Zhu Yasheng, Qiu Shengzhi, Wang Tao, Zhang Ling
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China.
Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou 221004, Jiangsu, China.
Int J Mol Sci. 2016 Jul 15;17(7):1141. doi: 10.3390/ijms17071141.
Peptide deformylase (PDF) is a metalloprotease catalyzing the removal of a formyl group from newly synthesized proteins, which makes it an important antibacterial drug target. Given the importance of PDF inhibitors like actinonin in antibacterial drug discovery, several reported potent PDF inhibitors were used to develop pharmacophore models using the Galahad module of Sybyl 7.1 software. Generated pharmacophore models were composed of two donor atom centers, four acceptor atom centers and two hydrophobic groups. Model-1 was screened against the Zinc database and several compounds were retrieved as hits. Compounds with Qfit values of more than 60 were employed to perform a molecular docking study with the receptor Escherichia coli PDF, then compounds with docking score values of more than 6 were used to predict the in silico pharmacokinetic and toxicity risk via OSIRIS property explorer. Two known PDF inhibitors were also used to perform a molecular docking study with E. coli PDF as reference molecules. The results of the molecular docking study were validated by reproducing the crystal structure of actinonin. Molecular docking and in silico pharmacokinetic and toxicity prediction studies suggested that ZINC08740166 has a relatively high docking score of 7.44 and a drug score of 0.78.
肽脱甲酰基酶(PDF)是一种金属蛋白酶,可催化从新合成的蛋白质中去除甲酰基,这使其成为重要的抗菌药物靶点。鉴于像放线菌素这样的PDF抑制剂在抗菌药物发现中的重要性,几种已报道的强效PDF抑制剂被用于使用Sybyl 7.1软件的Galahad模块开发药效团模型。生成的药效团模型由两个供体原子中心、四个受体原子中心和两个疏水基团组成。针对锌数据库筛选模型-1,并检索到几种化合物作为命中物。Qfit值大于60的化合物用于与受体大肠杆菌PDF进行分子对接研究,然后对接得分值大于6的化合物用于通过OSIRIS性质探索器预测计算机模拟的药代动力学和毒性风险。还使用两种已知的PDF抑制剂与大肠杆菌PDF进行分子对接研究作为参考分子。通过再现放线菌素的晶体结构验证了分子对接研究的结果。分子对接以及计算机模拟的药代动力学和毒性预测研究表明,ZINC08740166具有相对较高的对接得分7.44和药物得分0.78。